MARKET OUTLOOK
Triton Market Research, in its report, has determined that the pulse oximeter market in Europe would surge at a CAGR of 5.29% over the projected period 2019-2028.
Germany, Spain, France, Italy, the United Kingdom, Russia and Rest of Europe comprise the pulse oximeter market in Europe.
France is a well-developed economy with several hospitals and a robust regulatory framework. The rising geriatric population, which is suffering from different respiratory diseases, is driving the growth of the pulse oximeter market in the country. The rise in risk factors like obesity, smoking and alcohol consumption is anticipated to increase the demand for pulse oximeter devices in France. According to the statistics by the World Health Organization, 5% to 7% of adults in France have asthma. This is likely to push the need for the pulse oximeter market further, thereby supplementing the market growth.
In the United Kingdom, approximately 2% to 4% of the total population suffers from sleep apnea. The gradually rising cases of sleep apnea and the growing public awareness are the crucial drivers of the pulse oximeter market. The UK has also witnessed a high occurrence of other chronic disorders, like COPD and CHD. All these factors are anticipated to create lucrative growth opportunities for the pulse oximeter market in the country over the forecast period.
COMPETITIVE OUTLOOK
Some of the players operating in the pulse oximeter market are Cas Medical Systems Inc (Acquired by Edwards Lifesciences), Smiths Medical Group Limited, GE Healthcare (General Electric Company), Zensorium, Welch Allyn and Opto Circuits Limited.